Atlas Trials

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Clinical trial NCT01710605 · UNKNOWN

Trial details

NCT number
NCT01710605
Sponsor
Institut Curie
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Ductal Infiltrating Metastatic Breast CancerHormone-receptors Positive Breast Cancer
Start date
2012-02-01
Primary completion
2018-09-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.